AlphaMadera's AlphaVal page computes AT&T Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag T as undervalued, fairly valued, or overvalued.

What is AT&T Inc.'s fair value?

Fair value for T is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value T?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from T's most recent reported fundamentals.

T - AT&T Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $29.35 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Strong

Trading 46.0% below fair value

Current Price $22.10

Bear Case $32.74 48.1% upside ($32.74 - $22.10) / $22.10 = 48.1% $3.11 × 12x P/E

Fair Value $40.92 85.2% upside ($40.92 - $22.10) / $22.10 = 85.2% $3.11 × 15x P/E

Bull Case $49.10 122.2% upside ($49.10 - $22.10) / $22.10 = 122.2% $3.11 × 18x P/E

Adjust Assumptions

P/E Multiple

15.2x

Adjusted EPS

3.11$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 7.1x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $29.35 from 62 analysts, using a 35% weight on analyst consensus. That produces an estimated intrinsic value of $40.92 per share.

Warnings

ℹ Wall Street's average price target is $29.35 (from 62 analysts). Our estimate is 61% above the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples